|
End-of-day quote
NORDIC GROWTH MARKET
2026-11-06
|
5-day change | 1st Jan Change | ||
| 1.000 SEK | -4.76% |
|
-3.85% | -69.33% |
Company Valuation: Nosium AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 21.06 | 28.5 | 30.38 | 11.7 | 12.76 | 11.16 |
| Change | - | 35.33% | 6.6% | -61.48% | 9.07% | -12.55% |
| Enterprise Value (EV) 1 | 22.12 | 22.65 | 31.07 | 15.96 | 15.44 | 9.743 |
| Change | - | 2.41% | 37.16% | -48.62% | -3.26% | -36.91% |
| P/E | -7.53x | -8.56x | -28.7x | -0.41x | -0.4x | -0.84x |
| PBR | 3.92x | 2.63x | 1.32x | 0.32x | 0.5x | 0.43x |
| PEG | - | 0.8x | 0.4x | -0x | 0x | 0x |
| Capitalization / Revenue | 2x | 1.68x | 1.96x | 0.63x | 1.79x | 2.27x |
| EV / Revenue | 2.1x | 1.34x | 2.01x | 0.85x | 2.16x | 1.98x |
| EV / EBITDA | -6.75x | -6.84x | -6.02x | -2.26x | -2.86x | -1.79x |
| EV / EBIT | -6.74x | -6.08x | -5.54x | -1.98x | -2.23x | -1.66x |
| EV / FCF | -2.88x | 35.5x | -6.64x | -1.02x | -3.28x | -3.65x |
| FCF Yield | -34.7% | 2.82% | -15.1% | -98.5% | -30.5% | -27.4% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -55.26 | -49.08 | -11.72 | -180.3 | -15.03 | -3.904 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 10.54 | 16.95 | 15.48 | 18.69 | 7.148 | 4.917 |
| EBITDA 1 | -3.277 | -3.31 | -5.163 | -7.07 | -5.403 | -5.441 |
| EBIT 1 | -3.282 | -3.726 | -5.603 | -8.057 | -6.918 | -5.865 |
| Net income 1 | -2.797 | -3.212 | -1.06 | -22.44 | -33.14 | -9.559 |
| Net Debt 1 | 1.059 | -5.846 | 0.6911 | 4.262 | 2.68 | -1.419 |
| Reference price 2 | 416.000 | 420.000 | 336.000 | 74.000 | 6.020 | 3.260 |
| Nbr of stocks (in thousands) | 50.6 | 67.8 | 90.4 | 158 | 2,120 | 3,424 |
| Announcement Date | 5/6/21 | 4/28/22 | 5/4/23 | 6/6/24 | 6/5/25 | 6/5/26 |
1SEK in Million2SEK
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 2.36M | |
| 24.21x | 4.56x | 16.68x | 2.66% | 383B | |
| 34.33x | 5.19x | 21.6x | 1.71% | 267B | |
| 19.26x | 2.91x | 12.85x | 3.26% | 142B | |
| 26.55x | 3.89x | 16.25x | 2.19% | 76.76B | |
| 17.72x | 4.33x | 20.06x | 4.75% | 66.54B | |
| 61.15x | 8.66x | 33.43x | 0.2% | 54.55B | |
| 41.56x | 6.6x | 29.01x | 2.27% | 49.95B | |
| 36.78x | 2.75x | 14.88x | 1.31% | 39.88B | |
| 24.58x | 1.8x | 11.46x | 2.06% | 21.71B | |
| Average | 31.79x | 4.52x | 19.58x | 2.27% | 110.16B | |
| Weighted average by Cap. | 28.87x | 4.61x | 18.77x | 2.4% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- MEDFIN Stock
- Valuation Nosium AB
Select your edition
All financial news and data tailored to specific country editions
